References
- Botox (OnabotulinumtoxinA) [package insert]. Irvine (Botox) [package insert]. Irvine: Allergan; 2011.
- Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 2010;30:793-803. https://doi.org/10.1177/0333102410364676
- Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010;30: 804-14. https://doi.org/10.1177/0333102410364677
- Wei J, Zhu X, Yang G, Shen J, Xie P, Zuo X, et al. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: a meta-analysis of randomized controlled trials. Brain Behav 2019;9:e01409.
- Calvani F, Santini S, Bartoletti E, Alhadeff A. Personal technique of microinfiltration with botulin toxin: the SINB technique (superficial injection needling botulinum). Plast Surg (Oakv) 2019;27:156-61. https://doi.org/10.1177/2292550318800330
- Carruthers A, Carruthers J. History of botulinum toxin for medical and aesthetic use. In: Cohen JL, Ozog DM, Porto DA, editors. Botulinum toxins: cosmetic and clinical applications. Hoboken: John Wiley & Sons Inc.; 2017. p. 1-12.
- Burgen AS, Dickens F, Zatman LJ. The action of botulinum toxin on the neuro-muscular junction. J Physiol 1949;109:10-24. https://doi.org/10.1113/jphysiol.1949.sp004364
- Brooks VB. The action of botulinum toxin on motor-nerve filaments. J Physiol 1954;123:501-15. https://doi.org/10.1113/jphysiol.1954.sp005067
- Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87:1044-9. https://doi.org/10.1016/s0161-6420(80)35127-0
- Lipham WJ. A brief history of the clinical applications of botulinum toxin. In: Lipham WJ, editor. Cosmetic and clinical applications of botulinum toxin. Thorofare: SLACK; 2004. p. 1-3.
- Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum: a exotoxin. J Dermatol Surg Oncol 1992;18:17-21. https://doi.org/10.1111/j.1524-4725.1992.tb03295.x
- Ahn KY, Park MY, Park DH, Han DG. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans. Plast Reconstr Surg 2000;105:778-84. https://doi.org/10.1097/00006534-200002000-00050
- Kane M, Donofrio L, Ascher B, Hexsel D, Monheit G, Rzany B, et al. Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations. J Drugs Dermatol 2010;9(1 Suppl):s7-22.
- Ahmed NY, Knowles R, Dehorter N. New insights into cholinergic neuron diversity. Front Mol Neurosci 2019;12:204. https://doi.org/10.3389/fnmol.2019.00204
- Sine SM. End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease. Physiol Rev 2012;92:1189-234. https://doi.org/10.1152/physrev.00015.2011
- Shone CC. Clostridium botulinum neurotoxins, their structures and modes of action. In: Watson DH, editor. Natural toxicants in foods. Chichester: Ellis Harwood Ltd; 1986. p. 11-57.
- Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 2004;75:951-7. https://doi.org/10.1136/jnnp.2003.034702
- Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Annu Rev Pharmacol Toxicol 1986;26:427-53. https://doi.org/10.1146/annurev.pa.26.040186.002235
- Black JD, Dolly JO. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol 1986;103:535-44. https://doi.org/10.1083/jcb.103.2.535
- Pijning AE, Chiu J, Yeo RX, Wong JW, Hogg PJ. Identification of allosteric disulfides from labile bonds in X-ray structures. R Soc Open Sci 2018;5:171058. https://doi.org/10.1098/rsos.171058
- Pearce LB, First ER, MacCallum RD, Gupta A. Pharmacologic characterization of botulinum toxin for basic science and medicine. Toxicon 1997;35:1373-412. https://doi.org/10.1016/S0041-0101(96)00180-8
- Brin MF, Dressler D, Aoki KR. Pharmacology of botulinum toxin therapy. In: Brin MF, Comella C, Jankovic J, editors. Dystonia: etiology, clinical feature, and treatment. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 93-108.
- Jung GS, Cho IK, Sung HM. Submandibular gland reduction using botulinum toxin type A for a smooth jawline. Plast Reconstr Surg Glob Open 2019;7:e2192. https://doi.org/10.1097/gox.0000000000002192
- Park MY, Ahn KY, Jung DS. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg 2003;29:477-83. https://doi.org/10.1097/00042728-200305000-00007
- Park MY, Ahn KY. The comparison of long-term effect of botox(R) injection on lower face contouring after single injection and long-term repeated injections by standardized photograph analysis. J Korean Soc Plast Reconstr Surg 2009;36:654-9.
- Park MY, Porto DA, Ahn KY. Contouring of the lower face and the lower leg and calf. In: Cohen JL, Ozog DM, Porto DA, editors. Botulinum toxins: cosmetic and clinical applications. Hoboken: John Wiley & Sons Inc.; 2017. p. 177-90.
- Lee JH, Lee KY, Kim JY, Son WH, Jeong JH, Gil Jeong Y, et al. Botulinum toxin injection-site selection for a smooth shoulder line: an anatomical study. Biomed Res Int 2017;2017:3092720. https://doi.org/10.1155/2017/3092720
- Al-Fouzan AF, Mokeem LS, Al-Saqat RT, Alfalah MA, Alharbi MA, Al-Samary AE. Botulinum toxin for the treatment of Gummv smile. J Contemp Dent Pract 2017;18:474-8. https://doi.org/10.5005/jp-journals-10024-2068
- Matarasso A, Matarasso SL, Brandt FS, Bellman B. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 1999;103:645-52. https://doi.org/10.1097/00006534-199902000-00043
- Bi M, Sun P, Li D, Dong Z, Chen Z. Intralesional injection of botulinum toxin type A compared with intralesional injection of corticosteroid for the treatment of hypertrophic scar and keloid: a systematic review and meta-analysis. Med Sci Monit 2019;25:2950-8. https://doi.org/10.12659/msm.916305
- Kandhari R, Kaur I, Sharma D. Mesococktails and mesoproducts in aesthetic dermatology. Dermatol Ther 2020;33:e14218. https://doi.org/10.1111/dth.14218
- Childers MK. Targeting the neuromuscular junction in skeletal muscles. Am J Phys Med Rehabil 2004;83(10 Suppl):S38-44. https://doi.org/10.1097/01.PHM.0000141129.23219.42
- Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z. Diffusion, spread, and migration of botulinum toxin. Mov Disord 2013;28:1775-83. https://doi.org/10.1002/mds.25582
- Carli L, Montecucco C, Rossetto O. Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg. Muscle Nerve 2009;40:374-80. https://doi.org/10.1002/mus.21343
- Stone HF, Zhu Z, Thach TQ, Ruegg CL. Characterization of diffusion and duration of action of a new botulinum toxin type A formulation. Toxicon 2011;58:159-67. https://doi.org/10.1016/j.toxicon.2011.05.012
- Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994;9: 31-9. https://doi.org/10.1002/mds.870090106
- Restani L, Antonucci F, Gianfranceschi L, Rossi C, Rossetto O, Caleo M. Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A). J Neurosci 2011;31:15650-9. https://doi.org/10.1523/JNEUROSCI.2618-11.2011
- Aoki KR. Botulinum toxin: a successful therapeutic protein. Curr Med Chem 2004;11:3085-92. https://doi.org/10.2174/0929867043363802
- Francisco GE, Tan H, Green M. Do botulinum toxins have a role in the management of neuropathic pain? A focused review. Am J Phys Med Rehabil 2012;91:899-909. https://doi.org/10.1097/PHM.0b013e31825a134b
- Dressler D, Benecke R. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 2003;49:34-8. https://doi.org/10.1159/000067023
- Tintner R, Gross R, Winzer UF, Smalky KA, Jankovic J. Autonomic function after botulinum toxin type A or B: a doubleblind, randomized trial. Neurology 2005;65:765-7. https://doi.org/10.1212/01.wnl.0000174433.76707.8c
- Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000;43(2 Pt 1):249-59. https://doi.org/10.1067/mjd.2000.105567
- Kim SH, Lee SJ, Kim HJ, Lee JH, Jeong HS, Suh IS. Aging-related changes in the mid-face skin elasticity in East Asian women. Arch Craniofac Surg 2019;20:158-63. https://doi.org/10.7181/acfs.2019.00213
Cited by
- Botulinum Toxin Type A Reconstituted with Lidocaine: A Report of 1000 Consecutive Cases vol.11, pp.10, 2021, https://doi.org/10.3390/app11104491
- Outcome Using Either Intradermal Botox Injection or Endoscopic Thoracic Sympathectomy for Patients with Primary Palmar Hyperhidrosis: A Comparative Study vol.8, pp.2, 2021, https://doi.org/10.3390/cosmetics8020041
- Ophthalmic adverse events following facial injections of botulinum toxin A: A systemic literature review vol.20, pp.8, 2021, https://doi.org/10.1111/jocd.14279
- Botulinum toxin type A treatment is associated with improved social and psychological behavior: A retrospective study vol.21, pp.1, 2021, https://doi.org/10.1111/jocd.14627